Skip to Content

CME Group Inc Class A

CME: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$485.00YsjDynzjlzxm

CME Earnings: Market Volatility and Higher Fees Lead to a Strong Open to 2023

Wide-moat-rated CME Group reported strong first-quarter earnings as significant volatility, particularly in interest rate markets, drove high trading revenue. Net revenue increased 7% year over year and 19.4% sequentially to $1.44 billion, while earnings per share increased 24.6% from last year to $2.43. As we incorporate these results, we do not expect to materially alter our $215 fair value estimate for CME, and we view the shares as modestly undervalued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CME so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center